Argentina Clinical Laboratory Tests Market Size & Outlook

Hba1c tests was the largest segment with a revenue share of 12.4% in 2023. Horizon Databook has segmented the Argentina clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, liver panel tests, renal panel tests, lipid panel tests covering the revenue growth of each sub-segment from 2018 to 2030.

Biotechnology and pharmaceutical industries prefer Argentina for clinical research due to easy patient recruitment. Moreover, people in Argentina do not have health coverage and in some cases, very limited access to basic healthcare. Hence, there are many treatment-naïve patients to recruit for clinical trials. 

The ANMAT sites also reduce the overhead of recruiting & managing clinical trials. This is expected to improve the clinical laboratory tests for clinical trials and drug development. The high burden of diseases has increased the interest of hospitals in launching clinical laboratories in the country. 

For instance, in February 2023, Tenaris, a manufacturer of pipes, along with San Jose Municipal Hospital in Campana, launched a new laboratory in the country to improve the capability of testing in Argentina. Such initiatives are expected to support the market growth in Argentina and make the market in the country competitive.